← back to search

Cornelia Feiterna‐Sperling

Charité - Universitätsmedizin Berlin · DE
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include HIV/AIDS Research and Interventions, Tuberculosis Research and Epidemiology, HIV/AIDS drug development and treatment, and Pneumocystis jirovecii pneumonia detection and treatment.
h-index
20
citations
1,342
works
89
NIH funding
primary concept
Medicine
email

Recent publications

Immunopathogenic and clinical implications of advanced tissue analysis in non-tuberculous mycobacterial infections in children
Frontiers in Immunology 2025cited by 2position: middledoi
Tuberculosis outbreak in a German daycare center
Infection 2025cited by 1position: firstdoi
Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study
Clinical Infectious Diseases 2024cited by 6position: middledoi
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
Respiration 2024cited by 4position: middledoi
Refugees from Ukraine: children and adolescents with HIV in Germany
The Lancet HIV 2023cited by 7position: firstdoi
Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin
Pneumologie 2023cited by 5position: middledoi
Tuberkulose im Erwachsenenalter
Pneumologie 2022cited by 37position: middledoi
Pilot study to identify missed opportunities for prevention of childhood tuberculosis
European Journal of Pediatrics 2022cited by 5position: firstdoi
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study
Hepatology 2021cited by 57position: middledoi
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection
Hepatology 2019cited by 60position: middledoi
Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants
European Journal of Pediatrics 2019cited by 13position: lastdoi
S2k-Leitlinie: Tuberkulose im Erwachsenenalter
Pneumologie 2017cited by 122position: middledoi
S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter
Pneumologie 2017cited by 46position: firstdoi
Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature
Medical Microbiology and Immunology 2017cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Renate Krüger · MSB Medical School Berlin5 papers (2019–2025)Folke Brinkmann · Medizinische Hochschule Hannover5 papers (2017–2024) · 5 papers (2017–2024)Walter Haas · Robert Koch Institute5 papers (2017–2023)Elvira Richter · London School of Hygiene & Tropical Medicine4 papers (2017–2024) · 4 papers (2017–2024) · 4 papers (2017–2024) · 4 papers (2017–2023) · 4 papers (2017–2024) · 4 papers (2017–2024) · 4 papers (2017–2024)Jan Heyckendorf · Charité - Universitätsmedizin Berlin4 papers (2017–2024) · 4 papers (2017–2024)Christoph Lange · Médecins Sans Frontières4 papers (2017–2024)Torsten Bauer · Universitat de Barcelona3 papers (2017–2023) · 3 papers (2022–2024)Florian P. Maurer · University Medical Center Hamburg-Eppendorf3 papers (2022–2024)Katharina Weizsäcker · Médecins Sans Frontières3 papers (2017–2019) · 3 papers (2022–2024)Helmut J.F. Salzer · Semmelweis University3 papers (2022–2024)